HGHFX: The Hartford Healthcare Fund - MutualFunds.com

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Fixed income news, reports, video and more.

Municipal bonds news, reports, video and more.

Practice management news, reports, video and more.

Portfolio management news, reports, video and more.

Retirement news, reports, video and more.

Learn from industry thought leaders and expert market participants.

Deepen your understanding of Responsible Investing.

Enhance retirement outcomes with helpful tactics.

HGHFX - Snapshot

Vitals

  • YTD Return 16.2%
  • 3 Yr Annualized Return 12.9%
  • 5 Yr Annualized Return 10.6%
  • Net Assets $1.47 B
  • Holdings in Top 10 40.7%

52 WEEK LOW AND HIGH

$46.73
$29.81
$47.75

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.91%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 35.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $1,000,000
  • IRA N/A

Fund Classification


Compare HGHFX to Popular Health Care Sector Equity Funds and ETFs

Overview

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

$220.18

-0.36%

$46.04 B

1.10%

$2.43

5.75%

-

$108.44

-0.37%

$22.44 B

1.51%

$1.65

7.44%

-

$98.64

+0.04%

$15.09 B

0.05%

$0.05

21.13%

-

$106.08

-0.29%

$12.74 B

1.20%

$1.27

10.56%

-

$212.12

-0.21%

$12.74 B

1.20%

$2.55

12.13%

-

HGHFX - Profile

Distributions

  • YTD Total Return 16.2%
  • 3 Yr Annualized Total Return 12.9%
  • 5 Yr Annualized Total Return 10.6%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.06%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    The Hartford Healthcare Fund
  • Fund Family Name
    Hartford Mutual Funds
  • Inception Date
    Feb 28, 2017
  • Shares Outstanding
    N/A
  • Share Class
    Other
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Ann Gallo

Fund Description

Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser, Wellington Management Company LLP ("Wellington Management"). The fund takes a broad approach to investing in the health care sector. It may invest in health-related companies, including companies in the pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services and emerging health-related subsectors.


HGHFX - Performance

Return Ranking - Trailing

Period HGHFX Return Category Return Low Category Return High Rank in Category (%)
YTD 16.2% -6.1% 122.9% 35.40%
1 Yr 22.6% -1.4% 132.6% 38.75%
3 Yr 12.9%* 0.8% 40.7% 29.37%
5 Yr 10.6%* -0.7% 29.6% 25.71%
10 Yr 16.5%* 8.1% 19.7% 28.46%

* Annualized

Return Ranking - Calendar

Period HGHFX Return Category Return Low Category Return High Rank in Category (%)
2019 26.2% 3.8% 63.8% 19.31%
2018 -9.6% -49.7% 21.5% 66.42%
2017 N/A -59.8% 54.4% N/A
2016 N/A -36.6% 11.6% N/A
2015 N/A -62.4% 27.9% N/A

Total Return Ranking - Trailing

Period HGHFX Return Category Return Low Category Return High Rank in Category (%)
YTD 16.2% -6.1% 122.9% 34.16%
1 Yr 22.6% -6.5% 132.6% 35.00%
3 Yr 12.9%* -0.3% 40.7% 26.57%
5 Yr 10.6%* -0.7% 29.6% 23.57%
10 Yr 16.5%* 8.1% 19.7% 27.64%

* Annualized

Total Return Ranking - Calendar

Period HGHFX Return Category Return Low Category Return High Rank in Category (%)
2019 26.2% 3.8% 63.8% 19.31%
2018 -9.6% -25.3% 22.2% 69.34%
2017 N/A -10.8% 54.4% N/A
2016 N/A -36.6% 11.6% N/A
2015 N/A -16.6% 27.9% N/A

NAV & Total Return History


HGHFX - Holdings

Concentration Analysis

HGHFX Category Low Category High HGHFX % Rank
Net Assets 1.47 B 3.74 M 46 B 32.56%
Number of Holdings 124 24 426 20.93%
Net Assets in Top 10 603 M 952 K 19.6 B 34.30%
Weighting of Top 10 40.69% 14.0% 75.7% 48.84%

Top 10 Holdings

  1. UnitedHealth Group Inc 7.78%
  2. Pfizer Inc 5.80%
  3. Thermo Fisher Scientific Inc 4.79%
  4. Danaher Corp 3.98%
  5. Bristol-Myers Squibb Company 3.62%
  6. Abbott Laboratories 3.53%
  7. Eli Lilly and Co 3.21%
  8. Boston Scientific Corp 2.85%
  9. Becton, Dickinson and Co 2.60%
  10. Edwards Lifesciences Corp 2.58%

Asset Allocation

Weighting Return Low Return High HGHFX % Rank
Stocks
98.34% 61.47% 102.50% 47.67%
Cash
1.66% -0.01% 32.46% 42.44%
Preferred Stocks
0.00% 0.00% 6.63% 75.58%
Other
0.00% -2.50% 6.07% 70.93%
Convertible Bonds
0.00% 0.00% 0.06% 68.60%
Bonds
0.00% 0.00% 16.11% 70.35%

Stock Sector Breakdown

Weighting Return Low Return High HGHFX % Rank
Healthcare
99.93% 61.81% 100.00% 37.79%
Financial Services
0.07% 0.00% 3.31% 27.91%
Utilities
0.00% 0.00% 0.00% 68.02%
Technology
0.00% 0.00% 15.86% 73.84%
Real Estate
0.00% 0.00% 6.03% 72.09%
Industrials
0.00% 0.00% 5.94% 72.67%
Energy
0.00% 0.00% 0.00% 68.02%
Communication Services
0.00% 0.00% 4.69% 70.93%
Consumer Defense
0.00% 0.00% 34.31% 71.51%
Consumer Cyclical
0.00% 0.00% 1.09% 70.93%
Basic Materials
0.00% 0.00% 2.60% 80.23%

Stock Geographic Breakdown

Weighting Return Low Return High HGHFX % Rank
US
81.52% 47.91% 99.98% 48.26%
Non US
16.82% 0.00% 43.79% 47.09%

HGHFX - Expenses

Operational Fees

HGHFX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.91% 0.08% 25.14% 58.43%
Management Fee 0.86% 0.00% 1.25% 83.14%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.40% N/A

Sales Fees

HGHFX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

HGHFX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

HGHFX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 35.00% 0.70% 252.00% 44.79%

HGHFX - Distributions

Dividend Yield Analysis

HGHFX Category Low Category High HGHFX % Rank
Dividend Yield 0.00% 0.00% 3.15% 74.42%

Dividend Distribution Analysis

HGHFX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Quarterly Annually

Net Income Ratio Analysis

HGHFX Category Low Category High HGHFX % Rank
Net Income Ratio 0.06% -2.53% 2.53% 45.51%

Capital Gain Distribution Analysis

HGHFX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

HGHFX - Fund Manager Analysis

Managers

Ann Gallo


Start Date

Tenure

Tenure Rank

May 01, 2000

20.52

20.5%

Ann C. Gallo, Senior Managing Director, and Global Industry Analyst of Wellington Management, joined as an investment professional in 1998. Prior to that, Ann was a health care analyst with BT Alex. Brown (1995 — 1998). She was an investment banker and a health care analyst at Piper Jaffray in Minneapolis (1992 — 1995). Previously, she was a financial analyst with Citibank N.A. (1991 — 1992) and an accountant with Coopers & Lybrand (1987 — 1989). Ann received her MS from the Massachusetts Institute of Technology and her BS in accounting from Boston College.

Jean Hynes


Start Date

Tenure

Tenure Rank

May 01, 2000

20.52

20.5%

Jean M. Hynes, CFA, Senior Managing Director and Global Industry Analyst of Wellington Management, has been involved in portfolio management and securities analysis for the health science portion of the Fund since August 2003. Jean holds a BA in economics from Wellesley College (1991). She joined Wellington Management upon her graduation. She holds the Chartered Financial Analyst designation, and is a member of the CFA Institute and the Boston Security Analysts Society.

Robert Deresiewicz


Start Date

Tenure

Tenure Rank

May 01, 2000

20.52

20.5%

Robert L. Deresiewicz, Senior Managing Director, and Global Industry Analyst of Wellington Management, joined as an investment professional in 2000. Prior to that, Bob was an Assistant Professor of Medicine at the Harvard Medical School, and an Associate Physician in the Division of Infectious Diseases at the Brigham and Women's Hospital (1990 — 1998). Bob received his MBA from the Harvard Business School (2000), his MD from the Mount Sinai School of Medicine, and his BA in biochemistry summa cum laude from Columbia University.

Rebecca Sykes


Start Date

Tenure

Tenure Rank

Sep 01, 2020

0.16

0.2%

Rebecca D. Sykes, CFA, Senior Managing Director and Global Industry Analyst of Wellington Management, joined Wellington Management in 2007 and has been an investment professional since 2005.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.09 23.14 7.28 20.52
Continue to site >
Trending ETFs